erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with erythromycin
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Van Herwaarden MA et al. | The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. | 2000 | Aliment. Pharmacol. Ther. | pmid:10759625 |
Ramirez B and Richter JE | Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. | 1993 | Aliment. Pharmacol. Ther. | pmid:8094981 |
Catnach SM et al. | Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man. | 1993 | Aliment. Pharmacol. Ther. | pmid:8439638 |
Verhagen MA et al. | Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. | 1997 | Aliment. Pharmacol. Ther. | pmid:9663833 |
Talley NJ et al. | Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. | 2000 | Aliment. Pharmacol. Ther. | pmid:11121915 |
Emmanuel AV et al. | Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. | 2004 | Aliment. Pharmacol. Ther. | pmid:15023171 |
Netzer P et al. | Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. | 2002 | Aliment. Pharmacol. Ther. | pmid:12182748 |
Athanasakis E et al. | Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects. | 2002 | Aliment. Pharmacol. Ther. | pmid:12182757 |
McCallum RW and Cynshi O | Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. | 2007 | Aliment. Pharmacol. Ther. | pmid:17894654 |
Chen CL et al. | Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. | 2002 | Aliment. Pharmacol. Ther. | pmid:11929393 |
Winstead NS and Wilcox CM | Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. | 2007 | Aliment. Pharmacol. Ther. | pmid:17848180 |
Brand RM et al. | Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. | 1997 | Aliment. Pharmacol. Ther. | pmid:9218087 |
Annese V et al. | Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. | 1997 | Aliment. Pharmacol. Ther. | pmid:9218089 |
van Erpecum KJ et al. | Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones. | 2000 | Aliment. Pharmacol. Ther. | pmid:10903008 |
Chiba T et al. | Motilides accelerate regional gastrointestinal transit in the dog. | 2000 | Aliment. Pharmacol. Ther. | pmid:10886053 |
Landry C et al. | Could oral erythromycin optimize high energy continuous enteral nutrition? | 1996 | Aliment. Pharmacol. Ther. | pmid:8971296 |
Ehrenpreis ED et al. | Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. | 1998 | Aliment. Pharmacol. Ther. | pmid:9690728 |
Curry JI et al. | Review article: erythromycin as a prokinetic agent in infants and children. | 2001 | Aliment. Pharmacol. Ther. | pmid:11328252 |
Kendall BJ et al. | The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. | 1997 | Aliment. Pharmacol. Ther. | pmid:9146779 |
Mosonyi L et al. | [Infectious and neoplastic complications in rheumatoid arthritis]. | 1974-1975 | Allerg Immunol (Leipz) | pmid:4282826 |
Sabbah A et al. | [Cell-mediated immunity in antibiotic therapy]. | 1988 | Allerg Immunol (Paris) | pmid:3401307 |
Sabbah A | [Teldane update. Interview with Dr. Alfred Sabbah, chief of the immuno-allergology laboratory of the C.H.U. d'Angers. Interview by Dr. Pierre Ceddaha]. | 1993 | Allerg Immunol (Paris) | pmid:8466639 |
Wessel F | [Peri-anesthesia allergies to antibiotics]. | 1998 | Allerg Immunol (Paris) | pmid:9684043 |
López Serrano C et al. | Urticaria from erythromycin. | 1993 Nov-Dec | Allergol Immunopathol (Madr) | pmid:7512783 |
San Pedro de Saenz B et al. | FDE to macrolides. | 2002 | Allergy | pmid:11991294 |
Florido Lopez JF et al. | Fixed eruption due to erythromycin. A case report. | 1991 | Allergy | pmid:1826819 |
Adamson L and Walum E | Insulin and IGF-1 mediated inhibition of apoptosis in CHO cells grown in suspension in a protein-free medium. | 2007 | Altern Lab Anim | pmid:17650954 |
Asnes RS and Grebin B | Practical antibiotic therapy in children. | 1973 | Am Fam Physician | pmid:4546004 |
Snydman DR | Campylobacter Gastroenteritis. | 1982 | Am Fam Physician | pmid:7055019 |
Miller KE | Diagnosis and treatment of Chlamydia trachomatis infection. | 2006 | Am Fam Physician | pmid:16669564 |
McSherry JA | Mycoplasma pneumoniae infections. | 1983 | Am Fam Physician | pmid:6837403 |
Guckian JC | Complications of antimicrobial therapy. | 1973 | Am Fam Physician | pmid:4353071 |
Pagano JS and Sarubbi FA | Pneumonia. | 1972 | Am Fam Physician | pmid:4642154 |
Langer R and Binnick S | Treatment of acne vulgaris. | 1979 | Am Fam Physician | pmid:157066 |
Raz R and Bitnun S | Dilemmas of streptococcal pharyngitis. | 1987 | Am Fam Physician | pmid:3105301 |
Stott GA | New macrolide antibiotics: clarithromycin and azithromycin. | 1992 | Am Fam Physician | pmid:1325106 |
Constantine PA | Antibiotic therapy and serum digoxin toxicity. | 1998 | Am Fam Physician | pmid:9531908 |
Robinson M | Prokinetic therapy for gastroesophageal reflux disease. | 1995 | Am Fam Physician | pmid:7653432 |
Derrick CW and Dillon HC | Impetigo contagiosa. | 1971 | Am Fam Physician | pmid:5000340 |
Winkelman L | Recommended revision to endocarditis prophylaxis. | 1991 | Am Fam Physician | pmid:1950954 |
Kiselica D | Group A beta-hemolytic streptococcal pharyngitis: current clinical concepts. | 1994 | Am Fam Physician | pmid:8154403 |
Syphilis--recommended treatment schedules, 1976. | 1976 | Am Fam Physician | pmid:961559 | |
Luft FC | Antimicrobials in kidney and liver failure. | 1976 | Am Fam Physician | pmid:941822 |
Ackley AM | Legionnaires' disease: an update. | 1981 | Am Fam Physician | pmid:7020390 |
Johnson WT | Managing odontogenic infections. | 1984 | Am Fam Physician | pmid:6731235 |
Gonorrhea--recommended treatment schecules, 1974. | 1975 | Am Fam Physician | pmid:123699 | |
Culp ER | Ilosone update. | 1980 | Am Fam Physician | pmid:7377065 |
Ocular prophylaxis for gonococcal ophthalmia neonatorum: reaffirmation recommendation statement. | 2012 | Am Fam Physician | pmid:22335221 | |
Tan HH | Antibacterial therapy for acne: a guide to selection and use of systemic agents. | 2003 | Am J Clin Dermatol | pmid:12688836 |
Taylor GA and Shalita AR | Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. | 2004 | Am J Clin Dermatol | pmid:15301572 |